Accendra Health Inc (ACH) - Net Assets
Based on the latest financial reports, Accendra Health Inc (ACH) has net assets worth $-464.76 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.42 Billion) and total liabilities ($2.88 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Accendra Health Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-464.76 Million |
| % of Total Assets | -19.24% |
| Annual Growth Rate | N/A |
| 5-Year Change | -149.12% |
| 10-Year Change | -148.02% |
| Growth Volatility | 38.37 |
Accendra Health Inc - Net Assets Trend (1985–2025)
This chart illustrates how Accendra Health Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see ACH market cap.
Annual Net Assets for Accendra Health Inc (1985–2025)
The table below shows the annual net assets of Accendra Health Inc from 1985 to 2025. Also explore net asset momentum of Accendra Health Inc to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-460.98 Million | -181.56% |
| 2024-12-31 | $565.23 Million | -38.84% |
| 2023-12-31 | $924.17 Million | -2.27% |
| 2022-12-31 | $945.60 Million | +0.76% |
| 2021-12-31 | $938.50 Million | +31.80% |
| 2020-12-31 | $712.05 Million | +54.07% |
| 2019-12-31 | $462.15 Million | -10.85% |
| 2018-12-31 | $518.42 Million | -48.95% |
| 2017-12-31 | $1.02 Billion | +5.77% |
| 2016-12-31 | $960.04 Million | -3.28% |
| 2015-12-31 | $992.59 Million | +0.18% |
| 2014-12-31 | $990.84 Million | -3.34% |
| 2013-12-31 | $1.03 Billion | +5.28% |
| 2012-12-31 | $973.66 Million | +5.92% |
| 2011-12-31 | $919.22 Million | +7.20% |
| 2010-12-31 | $857.52 Million | +11.48% |
| 2009-12-31 | $769.18 Million | +10.66% |
| 2008-12-31 | $695.10 Million | +13.14% |
| 2007-12-31 | $614.36 Million | +12.22% |
| 2006-12-31 | $547.45 Million | +6.93% |
| 2005-12-31 | $512.00 Million | +11.24% |
| 2004-12-31 | $460.26 Million | +12.16% |
| 2003-12-31 | $410.36 Million | +51.18% |
| 2002-12-31 | $271.44 Million | -26.29% |
| 2001-12-31 | $368.24 Million | +6.81% |
| 2000-12-31 | $344.77 Million | +9.66% |
| 1999-12-31 | $314.40 Million | +7.27% |
| 1998-12-31 | $293.10 Million | +13.04% |
| 1997-12-31 | $259.30 Million | +6.97% |
| 1996-12-31 | $242.40 Million | +3.02% |
| 1995-12-31 | $235.30 Million | -8.12% |
| 1994-12-31 | $256.10 Million | +87.07% |
| 1993-12-31 | $136.90 Million | +17.31% |
| 1992-12-31 | $116.70 Million | +20.19% |
| 1991-12-31 | $97.10 Million | +14.24% |
| 1990-12-31 | $85.00 Million | +9.54% |
| 1989-12-31 | $77.60 Million | +0.52% |
| 1988-12-31 | $77.20 Million | +9.04% |
| 1987-12-31 | $70.80 Million | +73.11% |
| 1986-12-31 | $40.90 Million | +13.93% |
| 1985-12-31 | $35.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Accendra Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5217.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $152.78 Million | % |
| Other Comprehensive Income | $-885.00K | % |
| Other Components | $466.88 Million | % |
| Total Equity | $-460.98 Million | 100.00% |
Accendra Health Inc Competitors by Market Cap
The table below lists competitors of Accendra Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bien Sparebank ASA
OL:BIEN
|
$84.88 Million |
|
DT Cloud Star Acquisition Corporation Units
NASDAQ:DTSQU
|
$84.88 Million |
|
Kyungin Synthe
KO:012610
|
$84.89 Million |
|
Choppies Enterprises Ltd
JSE:CHP
|
$84.90 Million |
|
Max India Limited
NSE:MAXIND
|
$84.74 Million |
|
Niloerngruppen AB Series B
ST:NIL-B
|
$84.73 Million |
|
Chemcon Speciality Chemicals Limited
NSE:CHEMCON
|
$84.73 Million |
|
Powerlong Real Estate Holdings Limited
F:PW5
|
$84.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Accendra Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 565,226,000 to -460,978,000, a change of -1,026,204,000 (-181.6%).
- Net loss of 1,100,642,000 reduced equity.
- Share repurchases of 10,179,000 reduced equity.
- Other comprehensive income increased equity by 48,459,000.
- Other factors increased equity by 36,158,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.10 Billion | -238.76% |
| Share Repurchases | $10.18 Million | -2.21% |
| Other Comprehensive Income | $48.46 Million | +10.51% |
| Other Changes | $36.16 Million | +7.84% |
| Total Change | $- | -181.56% |
Book Value vs Market Value Analysis
This analysis compares Accendra Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $1.23 | $1.11 | x |
| 1986-12-31 | $1.37 | $1.11 | x |
| 1987-12-31 | $1.69 | $1.11 | x |
| 1988-12-31 | $1.83 | $1.11 | x |
| 1989-12-31 | $1.84 | $1.11 | x |
| 1990-12-31 | $2.01 | $1.11 | x |
| 1991-12-31 | $2.23 | $1.11 | x |
| 1992-12-31 | $2.65 | $1.11 | x |
| 1993-12-31 | $3.00 | $1.11 | x |
| 1994-12-31 | $5.49 | $1.11 | x |
| 1995-12-31 | $5.06 | $1.11 | x |
| 1996-12-31 | $5.09 | $1.11 | x |
| 1997-12-31 | $5.43 | $1.11 | x |
| 1998-12-31 | $3.30 | $1.11 | x |
| 1999-12-31 | $3.56 | $1.11 | x |
| 2000-12-31 | $4.03 | $1.11 | x |
| 2001-12-31 | $4.65 | $1.11 | x |
| 2002-12-31 | $4.86 | $1.11 | x |
| 2003-12-31 | $7.24 | $1.11 | x |
| 2004-12-31 | $7.76 | $1.11 | x |
| 2005-12-31 | $8.53 | $1.11 | x |
| 2006-12-31 | $8.98 | $1.11 | x |
| 2007-12-31 | $10.08 | $1.11 | x |
| 2008-12-31 | $11.07 | $1.11 | x |
| 2009-12-31 | $12.39 | $1.11 | x |
| 2010-12-31 | $13.71 | $1.11 | x |
| 2011-12-31 | $14.61 | $1.11 | x |
| 2012-12-31 | $15.49 | $1.11 | x |
| 2013-12-31 | $16.36 | $1.11 | x |
| 2014-12-31 | $15.92 | $1.11 | x |
| 2015-12-31 | $15.98 | $1.11 | x |
| 2016-12-31 | $15.71 | $1.11 | x |
| 2017-12-31 | $16.92 | $1.11 | x |
| 2018-12-31 | $8.64 | $1.11 | x |
| 2019-12-31 | $7.63 | $1.11 | x |
| 2020-12-31 | $11.21 | $1.11 | x |
| 2021-12-31 | $12.43 | $1.11 | x |
| 2022-12-31 | $12.41 | $1.11 | x |
| 2023-12-31 | $12.19 | $1.11 | x |
| 2024-12-31 | $7.37 | $1.11 | x |
| 2025-12-31 | $-5.99 | $1.11 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Accendra Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -39.85%
- • Asset Turnover: 1.13x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (5.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 12.26% | 1.20% | 3.79x | 2.70x | $810.00K |
| 1986 | 11.98% | 1.05% | 3.69x | 3.10x | $810.00K |
| 1987 | 9.18% | 1.13% | 3.74x | 2.18x | $-580.00K |
| 1988 | 10.88% | 1.15% | 3.85x | 2.46x | $680.00K |
| 1989 | 3.22% | 0.26% | 3.68x | 3.33x | $-5.26 Million |
| 1990 | 10.35% | 0.72% | 4.20x | 3.41x | $300.00K |
| 1991 | 12.46% | 1.18% | 3.30x | 3.21x | $2.39 Million |
| 1992 | 17.48% | 1.73% | 4.29x | 2.35x | $8.73 Million |
| 1993 | 14.68% | 1.44% | 4.18x | 2.44x | $6.41 Million |
| 1994 | 3.08% | 0.33% | 2.76x | 3.39x | $-17.71 Million |
| 1995 | -4.80% | -0.38% | 3.47x | 3.65x | $-34.83 Million |
| 1996 | 5.36% | 0.43% | 4.44x | 2.80x | $-11.24 Million |
| 1997 | 9.37% | 0.78% | 4.37x | 2.75x | $-1.63 Million |
| 1998 | 12.48% | 0.65% | 4.29x | 4.46x | $3.99 Million |
| 1999 | 15.35% | 0.88% | 3.68x | 4.74x | $9.76 Million |
| 2000 | 15.55% | 0.94% | 4.04x | 4.08x | $11.81 Million |
| 2001 | 9.75% | 0.60% | 4.00x | 4.04x | $-589.30K |
| 2002 | 17.41% | 1.19% | 3.92x | 3.72x | $20.12 Million |
| 2003 | 13.07% | 1.26% | 4.06x | 2.55x | $12.61 Million |
| 2004 | 13.14% | 1.34% | 4.00x | 2.46x | $14.47 Million |
| 2005 | 12.58% | 1.34% | 3.89x | 2.42x | $13.22 Million |
| 2006 | 8.91% | 0.88% | 3.28x | 3.08x | $-5.99 Million |
| 2007 | 11.84% | 1.07% | 4.49x | 2.47x | $11.27 Million |
| 2008 | 13.54% | 1.29% | 4.06x | 2.59x | $24.42 Million |
| 2009 | 13.61% | 1.30% | 4.60x | 2.27x | $27.74 Million |
| 2010 | 12.90% | 1.36% | 4.46x | 2.12x | $24.83 Million |
| 2011 | 12.53% | 1.34% | 4.43x | 2.12x | $23.28 Million |
| 2012 | 11.20% | 1.22% | 4.04x | 2.27x | $11.64 Million |
| 2013 | 10.82% | 1.22% | 3.90x | 2.27x | $8.38 Million |
| 2014 | 6.71% | 0.70% | 3.45x | 2.76x | $-32.58 Million |
| 2015 | 10.42% | 1.06% | 3.52x | 2.80x | $4.15 Million |
| 2016 | 11.33% | 1.12% | 3.58x | 2.83x | $12.78 Million |
| 2017 | 7.17% | 0.78% | 2.76x | 3.32x | $-28.75 Million |
| 2018 | -84.30% | -4.64% | 2.50x | 7.28x | $-488.85 Million |
| 2019 | -13.50% | -0.68% | 2.53x | 7.88x | $-108.59 Million |
| 2020 | 4.20% | 0.35% | 2.54x | 4.68x | $-41.33 Million |
| 2021 | 23.61% | 2.26% | 2.77x | 3.77x | $127.74 Million |
| 2022 | 2.37% | 0.22% | 1.85x | 5.70x | $-72.17 Million |
| 2023 | -4.47% | -0.40% | 2.03x | 5.51x | $-133.72 Million |
| 2024 | -64.17% | -3.39% | 2.30x | 8.24x | $-419.21 Million |
| 2025 | 0.00% | -39.85% | 1.13x | 0.00x | $-1.05 Billion |
Industry Comparison
This section compares Accendra Health Inc's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,095,568,537
- Average return on equity (ROE) among peers: 11.21%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Accendra Health Inc (ACH) | $-464.76 Million | 12.26% | N/A | $84.85 Million |
| Akso Health Group ADR (AHG) | $14.01 Million | 25.25% | 0.60x | $807.33 Million |
| Cardinal Health Inc (CAH) | $1.79 Billion | 34.06% | 23.78x | $43.01 Billion |
| Cencora Inc. (COR) | $3.32 Billion | 10.40% | 2.38x | $50.53 Billion |
| Cosmos Health Inc. (COSM) | $-6.46 Million | 0.00% | 0.00x | $14.53 Million |
| EDAP TMS SA (EDAP) | $34.78 Million | 33.77% | 0.45x | $154.80 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $741.21K | -42.90% | 4.10x | $143.05 Million |
| EDAP TMS S.A. (FOCL) | $31.46 Million | -2.44% | 0.79x | $153.11 Million |
| Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) | $4.25 Million | 31.26% | 1.04x | $4.78 Million |
| Henry Schein Inc (HSIC) | $4.67 Billion | 11.52% | 0.84x | $7.86 Billion |
About Accendra Health Inc
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level pos… Read more